{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T13:28:32Z","timestamp":1771680512130,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012637","name":"University of the East","doi-asserted-by":"publisher","award":["RTI2018-100903-B-I00"],"award-info":[{"award-number":["RTI2018-100903-B-I00"]}],"id":[{"id":"10.13039\/501100012637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","award":["DGM AND FPU18\/01559"],"award-info":[{"award-number":["DGM AND FPU18\/01559"]}],"id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","award":["FPU14\/05131"],"award-info":[{"award-number":["FPU14\/05131"]}],"id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014180","name":"Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["BES-2016-077235"],"award-info":[{"award-number":["BES-2016-077235"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["LE011P17"],"award-info":[{"award-number":["LE011P17"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.bcp.2020.113924","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T12:00:40Z","timestamp":1584964840000},"page":"113924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Abcg2 transporter affects plasma, milk and tissue levels of meloxicam"],"prefix":"10.1016","volume":"175","author":[{"given":"Alba M.","family":"Garcia-Lino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Blanco-Paniagua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa N.","family":"Astorga-Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Alvarez-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafne","family":"Garcia-Mateos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indira","family":"Alvarez-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana I.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gracia","family":"Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2020.113924_b0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0006-2952(95)02111-6","article-title":"Meloxican: influence on arachidonic acid metabolism","volume":"51","author":"Engelhardt","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2020.113924_b0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2885.2004.00618.x","article-title":"PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology","volume":"27","author":"Lees","year":"2004","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2020.113924_b0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejpb.2006.07.003","article-title":"Improved absorption of meloxicam via salt formation with ethanolamines","volume":"65","author":"Han","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bcp.2020.113924_b0020","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/1091581812442939","article-title":"Meloxicam modulates oxidative stress status, inhibits prostaglandin E2, and abrogates apoptosis in carbon tetrachloride-induced rat hepatic injury","volume":"31","author":"Edfawy","year":"2012","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.bcp.2020.113924_b0025","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.pbb.2005.05.008","article-title":"Pharmacological evidence for the activation of Ca2+-activated K+ channels by meloxicam in the formalin test","volume":"81","author":"Ortiz","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bcp.2020.113924_b0030","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.3185","article-title":"Meloxicam ameliorates the cartilage and subchondral bone deterioration in monoiodoacetate-induced rat osteoarthritis","volume":"5","author":"Nagy","year":"2017","journal-title":"PeerJ."},{"key":"10.1016\/j.bcp.2020.113924_b0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4103\/joacp.JOACP_133_18","article-title":"Meloxicam in the management of post-operative pain: narrative review","volume":"34","author":"Bekker","year":"2018","journal-title":"J. Anaesthesiol. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2020.113924_b0040","first-page":"370","article-title":"Long-lasting beneficial effects of periradicular injection of meloxicam for treating chronic low back pain and sciatica","volume":"79","author":"Borghi","year":"2013","journal-title":"Minerva Anestesiol."},{"key":"10.1016\/j.bcp.2020.113924_b0045","doi-asserted-by":"crossref","first-page":"24","DOI":"10.17116\/jnevro20181186124","article-title":"The efficacy of meloxicam in acute back pain: results of an observational non-interventional multicenter study","volume":"118","author":"Karateev","year":"2018","journal-title":"Zhurnal Nevrol. i Psikhiatrii Im. S.S. Korsakova."},{"key":"10.1016\/j.bcp.2020.113924_b0050","unstructured":"E. Medicines Agency, Metacam | European Medicines Agency, (n.d.). https:\/\/www.ema.europa.eu\/en\/medicines\/veterinary\/EPAR\/metacam (accessed August 5, 2019)."},{"key":"10.1016\/j.bcp.2020.113924_b0055","doi-asserted-by":"crossref","first-page":"E2372","DOI":"10.3390\/nu11102372","article-title":"Transporters in the mammary gland\u2014contribution to presence of nutrients and drugs into milk","volume":"11","author":"Garc\u00eda-Lino","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2020.113924_b0060","article-title":"Report for 2016 on the results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products","volume":"15","author":"European Food Safety Authority (EFSA)","year":"2018","journal-title":"EFSA Support. Publ."},{"key":"10.1016\/j.bcp.2020.113924_b0065","first-page":"115","article-title":"Clinical pharmacokinetics of meloxicam. A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug","author":"Nm","year":"1999","journal-title":"Clin. Pharmacol. 36"},{"key":"10.1016\/j.bcp.2020.113924_b0070","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1177\/0748233714538484","article-title":"Effects of nonsteroidal anti-inflammatory meloxicam on stomach, kidney, and liver of rats","volume":"32","author":"Burukoglu","year":"2016","journal-title":"Toxicol. Ind. Health."},{"key":"10.1016\/j.bcp.2020.113924_b0075","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.biopha.2018.08.162","article-title":"Metabolism of liver CYP450 and ultrastructural changes after long-term administration of aspirin and ibuprofen","volume":"108","author":"Wen","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2020.113924_b0080","first-page":"427","article-title":"Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP\/ABCG2)","volume":"1","author":"Allen","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcp.2020.113924_b0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/jpet.106.110379","article-title":"Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2\/ABCC2- and MRP4\/ABCC4-mediated methotrexate transport","volume":"320","author":"El-Sheikh","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2020.113924_b0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/dmd.108.023200","article-title":"Transport of diclofenac by BCRP (ABCG2) and stimulation of MRP2- (ABCC2-) mediated drug transport by diclofenac and benzbromarone","volume":"37","author":"Lagas","year":"2008","journal-title":"Drug Metab Dispos."},{"key":"10.1016\/j.bcp.2020.113924_b0095","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1124\/mol.109.062364","article-title":"Hepatic clearance of reactive glucuronide metabolites of diclofenac in the mouse is dependent on multiple ATP-binding cassette efflux transporters","volume":"77","author":"Lagas","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2020.113924_b0100","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1124\/dmd.118.085506","article-title":"Role of ABCG2 in secretion into milk of the anti-inflammatory flunixin and its main metabolite: in vitro-in vivo correlation in mice and cows","volume":"47","author":"Garcia-Mateos","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2020.113924_b0105","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/jnci\/92.20.1651","article-title":"Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan","volume":"92","author":"Jonker","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bcp.2020.113924_b0110","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s11095-014-1609-7","article-title":"Brain and testis accumulation of regorafenib is restricted by breast cancer resistance protein (BCRP\/ABCG2) and P-glycoprotein (P-GP\/ABCB1)","volume":"32","author":"Kort","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bcp.2020.113924_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104297","article-title":"Brain accumulation of osimertinib and its active metabolite AZ5104 is restricted by ABCB1 (P-glycoprotein) and ABCG2 (breast cancer resistance protein)","volume":"146","author":"van Hoppe","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2020.113924_b0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2885.2011.01313.x","article-title":"ABCG2 transporter: therapeutic and physiologic implications in veterinary species","volume":"35","author":"Mealey","year":"2012","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2020.113924_b0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejps.2011.10.021","article-title":"Antibody binding shift assay for rapid screening of drug interactions with the human ABCG2 multidrug transporter","volume":"45","author":"Telbisz","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bcp.2020.113924_b0130","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1124\/dmd.113.055970","article-title":"Role of ABCG2 in transport of the mammalian lignan enterolactone and its secretion into milk in abcg2 knockout mice","volume":"42","author":"Miguel","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2020.113924_b0135","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jff.2017.06.038","article-title":"The Breast Cancer Resistance Protein (BCRP\/ABCG2) influences the levels of enterolignans and their metabolites in plasma, milk and mammary gland","volume":"35","author":"Garc\u00eda-Mateos","year":"2017","journal-title":"J. Funct. Foods."},{"key":"10.1016\/j.bcp.2020.113924_b0140","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1124\/dmd.112.049056","article-title":"The bovine ATP-binding cassette transporter ABCG2 Tyr581Ser single-nucleotide polymorphism increases milk secretion of the fluoroquinolone danofloxacin","volume":"41","author":"Otero","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2020.113924_b0145","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.3168\/jds.2015-10593","article-title":"Effect of bovine ABCG2 Y581S polymorphism on concentrations in milk of enrofloxacin and its active metabolite ciprofloxacin","volume":"99","author":"Otero","year":"2016","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.bcp.2020.113924_b0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tips.2005.11.007","article-title":"The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins","volume":"27","author":"van Herwaarden","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2020.113924_b0155","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1124\/dmd.115.068940","article-title":"The ABCG2 efflux transporter in the mammary gland mediates veterinary drug secretion across the blood-milk barrier into milk of dairy cows","volume":"44","author":"Mahnke","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2020.113924_b0160","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1080\/19440049.2014.908261","article-title":"Novel in vitro systems for prediction of veterinary drug residues in ovine milk and dairy products","volume":"31","author":"Gonz\u00e1lez-Lobato","year":"2014","journal-title":"Food Addit. Contam. Part A."},{"key":"10.1016\/j.bcp.2020.113924_b0165","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.tvjl.2012.09.012","article-title":"Inhibition of ABCG2\/BCRP transporter by soy isoflavones genistein and daidzein: effect on plasma and milk levels of danofloxacin in sheep","volume":"196","author":"Perez","year":"2013","journal-title":"Vet. J."},{"key":"10.1016\/j.bcp.2020.113924_b0170","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/jvp.12297","article-title":"Subcutaneous meloxicam suspension pharmacokinetics in mice and dose considerations for postoperative analgesia","volume":"39","author":"Chen","year":"2016","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2020.113924_b0175","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.trac.2004.04.001","article-title":"Trends in quality in the analytical laboratory. II. Analytical method validation and quality assurance","volume":"23","author":"Taverniers","year":"2004","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.bcp.2020.113924_b0180","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1124\/mol.104.010439","article-title":"The breast cancer resistance protein (BCRP\/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin","volume":"67","author":"Merino","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2020.113924_b0185","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/dmd.105.008219","article-title":"Breast cancer resistance protein (BCRP\/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion","volume":"34","author":"Merino","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2020.113924_b0190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/dmd.108.023200","article-title":"Transport of diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug transport by diclofenac and benzbromarone","volume":"37","author":"Lagas","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2020.113924_b0195","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2020.113924_b0200","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.addr.2008.08.007","article-title":"Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice","volume":"61","author":"Vlaming","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bcp.2020.113924_b0205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1472-8206.2011.00991.x","article-title":"Adverse drug reactions associated with the use of NSAIDs: a case\/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002\u20132006","volume":"27","author":"Lapeyre-Mestre","year":"2013","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2020.113924_b0210","first-page":"101","article-title":"The Cox-2 inhibitor meloxicam ameliorates neuroinflammation and depressive behavior in adult mice after splenectomy","volume":"3","author":"Haile","year":"2016","journal-title":"J. Neurophysiol. Neurol. Disord."},{"key":"10.1016\/j.bcp.2020.113924_b0215","first-page":"375","article-title":"Protective effect of meloxicam against acute radiation-induced brain injury in rats","volume":"30","author":"Han","year":"2014","journal-title":"Chinese J. Cell. Mol. Immunol."},{"key":"10.1016\/j.bcp.2020.113924_b0220","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.neuroscience.2018.07.054","article-title":"Pre-treatment with meloxicam prevents the spinal inflammation and oxidative stress in DRG neurons that accompany painful cervical radiculopathy","volume":"388","author":"Kartha","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2020.113924_b0225","first-page":"391","article-title":"Doxycycline and meloxicam can treat neuroinflammation by increasing activity of antioxidant enzymes in rat brain","volume":"32","author":"Dik","year":"2019","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.bcp.2020.113924_b0230","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8590578","article-title":"The role of reactive oxygen species in the pathogenesis of Alzheimer\u2019s disease, Parkinson\u2019s disease, and Huntington\u2019s disease: a mini review","volume":"2016","author":"Manoharan","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bcp.2020.113924_b0235","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s11011-016-9812-3","article-title":"Meloxicam-loaded nanocapsules as an alternative to improve memory decline in an Alzheimer\u2019s disease model in mice: involvement of Na+, K+-ATPase","volume":"31","author":"Ianiski","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bcp.2020.113924_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086806","article-title":"Transport rankings of non-steroidal antiinflammatory drugs across blood-brain barrier in vitro models","volume":"9","author":"Novakova","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.bcp.2020.113924_b0245","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1124\/dmd.110.037317","article-title":"Differential impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on axitinib brain accumulation and oral plasma pharmacokinetics","volume":"39","author":"Poller","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2020.113924_b0250","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.phrs.2017.11.006","article-title":"P-glycoprotein (MDR1\/ABCB1) and Breast Cancer Resistance Protein (BCRP\/ABCG2) affect brain accumulation and intestinal disposition of encorafenib in mice","volume":"129","author":"Wang","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2020.113924_b0255","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ijc.26000","article-title":"Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration","volume":"130","author":"Tang","year":"2012","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.bcp.2020.113924_b0260","first-page":"1","article-title":"Botryllamide G is an ABCG2 inhibitor that improves lapatinib delivery in mouse brain","author":"Strope","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bcp.2020.113924_b0265","unstructured":"Food and Drug Administration (FDA), Mobic\u00ae (meloxicam) tablets and oral suspension, n.d. www.fda.gov\/medwatch. (accessed August 8, 2019)."},{"key":"10.1016\/j.bcp.2020.113924_b0270","doi-asserted-by":"crossref","first-page":"10151","DOI":"10.3168\/jds.2018-14657","article-title":"Meloxicam administration either prior to or after parturition: effects on behavior, health, and production in dairy cows","volume":"101","author":"Swartz","year":"2018","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.bcp.2020.113924_b0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215842","article-title":"Plasma pharmacokinetic profile and efficacy of meloxicam administered subcutaneously and intramuscularly to sheep","volume":"14","author":"Woodland","year":"2019","journal-title":"PLoS One."},{"key":"10.1016\/j.bcp.2020.113924_b0280","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bcp.2017.10.004","article-title":"BCRP\/ABCG2 and high-alert medications: Biochemical, pharmacokinetic, pharmacogenetic, and clinical implications","volume":"147","author":"Hira","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2020.113924_b0285","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1124\/mol.105.011080","article-title":"Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP\/ABCG2) in liver","volume":"67","author":"Merino","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2020.113924_b0290","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jvp.12099","article-title":"Meloxicam pharmacokinetics using nonlinear mixed-effects modeling in ferrets after single subcutaneous administration","volume":"37","author":"Chinnadurai","year":"2014","journal-title":"J. Vet. Pharmacol. Ther."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220301520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220301520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:06:59Z","timestamp":1762096019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220301520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":58,"alternative-id":["S0006295220301520"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.113924","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abcg2 transporter affects plasma, milk and tissue levels of meloxicam","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.113924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113924"}}